17.01.2014 Views

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

serous and transitional cell <strong>carcinoma</strong><br />

and endometrioid and clear cell.<br />

Grading<br />

The least diff e rentiated component<br />

determines the tumour grade.<br />

Histogenesis<br />

Endometriosis, occasionally with atypia,<br />

is found in association with 53% of MEBT<br />

{2496} and up to 50% of mixed clear cellendometrioid<br />

tumours {2511}. Some<br />

cases show a transition from endometriosis<br />

to neoplastic epithelium.<br />

Somatic genetics<br />

It is impossible to make broad statements,<br />

as studies are limited to a few<br />

cases. LOH on chromosome 17, common<br />

in serous tumours, has been found<br />

in two of five mixed endometrioid-serous<br />

tumours {959}. PTEN mutation, which has<br />

been associated with the endometrioid<br />

type, has also been noted in a mixed<br />

mucinous-endometrioid tumour {2075}.<br />

KRAS mutations, an early event in mucinous<br />

tumours, have been noted in three<br />

mixed Brenner-mucinous tumours {589}.<br />

The mucinous cystadeno<strong>carcinoma</strong> and<br />

B renner tumour components share d<br />

amplification of 12q 14-21 in one MET,<br />

suggesting clonal relatedness {2207}.<br />

Prognosis and predictive factors<br />

The behaviour of MEBT is similar to that of<br />

endocervical-like mucinous bord e r l i n e<br />

tumours. The dominant cell type generally<br />

dictates behaviour. An exception is<br />

mixed endometrioid and serous <strong>carcinoma</strong>,<br />

which, even when the serous component<br />

is minor, behaves more aggressively<br />

than pure endometrioid <strong>carcinoma</strong><br />

and similarly to their serous counterpart.<br />

Mixed endometrioid and serous carc i n o-<br />

ma may recur as serous carc i n o m a<br />

{2907}. This finding stresses the importance<br />

of careful sampling of an<br />

endometrioid cystadeno<strong>carcinoma</strong> to rule<br />

out a mixed serous component.<br />

Undifferentiated <strong>carcinoma</strong><br />

D e f i n i t i o n<br />

A primary ovarian <strong>carcinoma</strong> with no diff<br />

e rentiation or only small foci of diff e re n t i-<br />

ation.<br />

ICD-O code 8 0 2 0 / 3<br />

E p i d e m i o l o g y<br />

When applying the WHO criteria, appro x-<br />

imately 4-5% of ovarian cancers are undiff<br />

e rentiated <strong>carcinoma</strong>. The frequency of<br />

u n d i ff e rentiated <strong>carcinoma</strong> was 4.1%<br />

when defined as <strong>carcinoma</strong>s with solid<br />

a reas as the predominant component re p-<br />

resenting over 50% of the tumour {2677}.<br />

Clinical features<br />

In the only large series the age of the<br />

patients ranged from 39-72 (mean, 54<br />

years) {2677}.<br />

M a c r o s c o p y<br />

M a c ro s c o p i c a l l y, undiff e rentiated carc i n o-<br />

ma does not have specific features. The<br />

tumours are predominantly solid, usually<br />

with extensive areas of necrosis.<br />

Tumour spread and staging<br />

A c c o rding to FIGO, 6% of the patients are<br />

d i s c o v e red in stage I, 3% are in stage II,<br />

74% in stage III and 17% in stage IV; thus<br />

91% of the tumours are discovered in<br />

stages III and IV {2677}.<br />

H i s t o p a t h o l o g y<br />

H i s t o l o g i c a l l y, undiff e rentiated carc i n o m a<br />

consists of solid groups of tumour cells<br />

with numerous mitotic figures and significant<br />

cytological atypia. Areas with a spindle<br />

cell component, microcystic pattern<br />

and focal vascular invasion can be seen.<br />

It is unusual to see an undiff e re n t i a t e d<br />

c a rcinoma without any other component<br />

of müllerian <strong>carcinoma</strong>. Usually, areas of<br />

high grade serous <strong>carcinoma</strong> are pre s e n t .<br />

Foci of transitional cell <strong>carcinoma</strong> can<br />

also be seen. Undiff e rentiated carc i n o m a<br />

of the ovary does not have a specific<br />

i m m u n o p h e n o t y p e .<br />

D i ff e rential diagnosis<br />

The main diff e rential diagnoses are granulosa<br />

cell tumour of the adult type, transitional<br />

cell <strong>carcinoma</strong>, poorly diff e re n t i a t e d<br />

squamous cell <strong>carcinoma</strong>, small cell <strong>carcinoma</strong><br />

and metastatic undiff e re n t i a t e d<br />

c a rcinoma.<br />

Granulosa cell tumours may have a diffuse<br />

pattern; however, it is unusual not to<br />

have also areas with a trabecular pattern ,<br />

Call-Exner bodies or areas showing sex<br />

c o rds. In addition, undiff e rentiated carc i-<br />

noma is a more anaplastic tumour with a<br />

larger number of mitotic figures.<br />

Transitional cell <strong>carcinoma</strong>s might have<br />

a reas of undiff e rentiated tumour; however,<br />

either a trabecular pattern or large papillae<br />

are always identified in the form e r.<br />

Small cell <strong>carcinoma</strong> of the hyperc a l-<br />

caemic type typically occurs in young<br />

women and often contains follicle-like<br />

s t r u c t u res. The cells of small cell carc i n o-<br />

ma of the pulmonary type show nuclear<br />

molding and have high nuclear to cytoplasmic<br />

ratios.<br />

F i n a l l y, metastatic undiff e rentiated carc i-<br />

nomas are uniform tumours without papill<br />

a ry areas.<br />

All these diff e rential diagnoses can usually<br />

be resolved when the tumour is well<br />

sampled, and areas with a diff e re n t<br />

m a c roscopic appearance are submitted.<br />

Sampling will identify the diff e rent components<br />

of the tumour that are characteristic<br />

of primary ovarian lesions.<br />

Prognosis and predictive factors<br />

The five-year survival of patients with<br />

u n d i ff e rentiated <strong>carcinoma</strong> is worse than<br />

that of ovarian serous or transitional cell<br />

c a rcinoma. Only 6% of these patients survive<br />

for 5 years.<br />

Unclassified adeno<strong>carcinoma</strong><br />

D e f i n i t i o n<br />

A primary ovarian adeno<strong>carcinoma</strong> that<br />

cannot be classified as one of the specific<br />

types of müllerian adenocarc i n o m a<br />

because it has overlapping features or is<br />

not sufficiently diff e rentiated. These<br />

tumours are uncommon.<br />

ICD-O code 8 1 4 0 / 3<br />

H i s t o p a t h o l o g y<br />

Tumours in this category would include<br />

well or moderately diff e rentiated tumours<br />

with overlapping features such as a mucinous<br />

tumour with cilia, or it might include<br />

a less diff e rentiated tumour without distinctive<br />

features of one of the mûllerian<br />

types of adenocarcoma.<br />

Prognosis and predictive factors<br />

Since this group of tumours has not yet<br />

been specifically studied, the prognosis is<br />

not known.<br />

Surface epithelial-stromal tumours 145

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!